{"id":6377,"date":"2024-07-23T11:30:59","date_gmt":"2024-07-23T09:30:59","guid":{"rendered":"https:\/\/www.bioga.org\/?p=6377"},"modified":"2024-07-23T11:42:18","modified_gmt":"2024-07-23T09:42:18","slug":"biotechnology-holds-a-prominent-role-in-the-policy-directions-for-the-next-european-commission-2024-2029","status":"publish","type":"post","link":"https:\/\/www.bioga.org\/en\/biotechnology-holds-a-prominent-role-in-the-policy-directions-for-the-next-european-commission-2024-2029\/","title":{"rendered":"Biotechnology holds a prominent role in the policy directions for the next European Commission 2024-2029"},"content":{"rendered":"
The guidelines presented by the President of the European Commission, Ursula von der Leyen, highlight biotechnology and the revolution stemming from its innovations as fundamental to the future of the European Union.<\/h6>\n

On July 18, 2024, the President of the\u00a0European Commission<\/strong><\/a>,\u00a0Ursula von der Leyen<\/strong>, elected for a second term held between June 6 and 9, presented her\u00a0policy directions for the next European Commission 2024-2029<\/strong><\/a>. These political guidelines, which will shape the future of the old continent, are set within a context characterized by\u00a0\u201cprofound changes affecting our society and security, our planet, and our economy,\u201d<\/strong>\u00a0as stated by Von der Leyen. \u201cThe next five years will define the position that Europe will occupy in the world over the next five decades. They will determine whether we build our own future or let events or others shape it,\u201d she warned.<\/p>\n

In this regard, she refers to the\u00a0\u201cdangers of dependence or the fragility of supply chains,\u201d<\/strong>\u00a0experienced in recent events such as the Covid-19 pandemic, China\u2019s monopoly on essential raw materials like chips and batteries, or what she defines as \u201cPutin\u2019s energy blackmail.\u201d \u201cEurope cannot afford to fall behind and lose its competitive edge in this race, nor present any weak flank,\u201d she asserts.<\/p>\n

In this vein, the President of the European Commission directly mentions\u00a0biotechnology\u00a0<\/strong>as\u00a0one of the keys to ensuring the strategic autonomy of the European Union<\/strong>, as well as one of the driving forces for Europe\u2019s future. \u201cI want Europe to fully embrace the biotech revolution,\u201d she states in the referred document. She emphasizes that\u00a0biotechnologies<\/strong>, supported by artificial intelligence and digital tools, can help completely modernize sectors such as agriculture and forestry, energy, or health.<\/p>\n

The commitment to biotechnology reflected in this document is evidenced by the proposal for a\u00a0new European Biotechnology Law in 2025<\/strong>, aimed at\u00a0facilitating the transition of biotechnology from the laboratory to the factory and its subsequent commercialization<\/strong>. This law will be part of a broader\u00a0European Life Sciences Strategy<\/strong>\u00a0to study how we can support our green and digital transitions and develop high-value technologies.<\/p>\n

Facing the goal of leading innovation, the document expresses\u00a0the need to create conditions that allow researchers to thrive<\/strong>. This objective requires\u00a0providing the infrastructure and innovative laboratories needed to test and develop ideas, through new public-private partnerships, such as joint ventures<\/strong>. Talent is fundamental for this, and efforts will be made not only to attract new talents but to ensure that \u201cthe best and brightest minds stay in Europe,\u201d by strengthening ties between research departments, higher education, and businesses, with particular reinforcement of alliances with universities. In this line, the expansion of the European Research Council and the European Innovation Council is announced.<\/p>\n

In terms of investment, the European Commission aims to make a significant push by unlocking the necessary funding for green, digital, and social transitions. Among the proposals in the document is the presentation of a new European Competitiveness Fund as part of the European Commission\u2019s proposal for a new and reinforced budget in the next multiannual financial framework.\u00a0This instrument will enable investment in strategic technologies such as biotechnology<\/strong>, artificial intelligence, the space industry, or clean technologies, to ensure the development of strategic technologies and their manufacturing in Europe. Additionally, it will also allow the potential of the budget to be leveraged to boost and reduce the risks of private investment in common goals.<\/p>\n

\u201cIn my opinion, the greatest challenges of our era, from security issues to climate change and competitiveness, can only be resolved through joint action. The threats we face are too great to address individually. The opportunities before us are too significant to seize separately,\u201d warns the President of the European Parliament in her speech.\u00a0Biotechnology plays a crucial role in this horizon, and its pivotal position for achieving strategic autonomy is firm<\/strong>, as evidenced by its presence not only in these community policy guidelines but also recently in the European Council\u2019s Strategic Agenda 2024-2029.<\/p>\n

Original news: Biotechnology holds a prominent role in the policy directions for the next European Commission 2024-2029 \u2013 AseBio (19\/07\/2024).<\/a><\/h6>\n
\n

For\u00a0BIOGA,<\/a>\u00a0it is a priority to promote intersectoral collaboration with other entities and to promote national and international networking activities. If you want to know more about us, please visit the following link.<\/strong><\/p>\n